hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG
about
Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationshipsMolecular aspects of thyroid hormone actionsThe emerging role of pituitary tumor transforming gene in tumorigenesisNonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosisHuman securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinasePTTG/securin activates expression of p53 and modulates its functionEctopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cellsThe influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferationGrowth retardation, polyploidy, and multinucleation induced by Clast3, a novel cell cycle-regulated proteinActivation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function.Effect of PTTG on endogenous gene expression in HEK 293 cells.Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.Methylation alterations are not a major cause of PTTG1 misregulation.Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 studyConstruction and clarification of dynamic gene regulatory network of cancer cell cycle via microarray data.Gene expression profiling of breast cancers with emphasis of beta-catenin regulationGenomic and epigenetic instability in colorectal cancer pathogenesis.Overexpression of the pituitary tumor transforming gene induces p53-dependent senescence through activating DNA damage response pathway in normal human fibroblasts.Down-regulation of the oncogene PTTG1 via the KLF6 tumor suppressor during induction of myeloid differentiation.Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteinsGlycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1/human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors.Cloning of Porcine Pituitary Tumor Transforming Gene 1 and Its Expression in Porcine Oocytes and EmbryosPTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell populationOverexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signallingPTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.Expression of pituitary tumor transforming gene in human gastric carcinomaNovel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription.PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosisProliferation marker securin identifies favourable outcome in invasive ductal breast cancer.PTTG: an important target gene for ovarian cancer therapy.Securin is a target of the UV response pathway in mammalian cellsSecurin promotes the identification of favourable outcome in invasive breast cancer.RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.Pituitary tumor-transforming gene and its binding factor in endocrine cancer.Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma
P2860
Q21195153-212A47F9-CFA4-441E-8C3F-6AD5061FC3D2Q22306217-7427F70B-9279-4619-A9C0-498ED8D64FB2Q24548764-9E93DBDF-CEA5-4DCC-8CA0-5CBC86C138BDQ24551182-8B30773F-BF77-47D5-BAE4-AFAB50456239Q24612772-AEE1D9EC-CB9D-4235-BE5E-D98EB38B5D65Q24792982-8969C9BA-DEBF-4707-BA88-A0363B28F307Q24798304-19742162-D464-498A-8284-8D87F758B746Q25257905-3E6B3032-452F-4934-978B-FD08FCD844CAQ28235902-7609BB0B-345C-4E3C-AF1B-B47875FB64BEQ28590702-1550D9B7-243D-4548-9D42-DFB68EA38F4DQ30168883-A844ED69-531C-4756-9233-B27A60762376Q30951807-A54D4A41-896F-4011-9565-97DFD1FC2F55Q33259832-37B7F8B8-0A52-49B3-AB54-09823F28D401Q33329701-09109476-D2F2-4ECC-A801-82D904D6EB8BQ33395678-7C0D8380-B7C2-4042-B49C-257C9605252AQ33449310-8F054041-5640-4B57-BF5A-9FCF230BDF5FQ33654773-B572D9BA-1F63-4472-A2F8-E46DFA58C7CDQ33836026-D4B46E83-13DE-41CA-A47F-839B4F1D256CQ33991337-FAEDA6C1-6FFE-4059-8AFE-8911C6FCA243Q34970802-E9CA6E71-FE31-4642-B7EB-50BE923237D0Q35070405-49EC95F1-96DB-4B90-8F69-D3CB8515A2B2Q35083801-0A568989-5E74-484B-922B-45B78586A8FBQ35314221-E41A3ACD-7FDC-4151-AF61-8CF570D1D02BQ35983584-6B8354C3-C704-46FA-9F77-CF227E834137Q36003861-0FDBCFD2-D20E-4014-B535-F256B5A474BEQ36053060-D2C2A980-9558-485E-8CB9-641615AE295AQ36126937-D74E914F-B05D-4C59-9B85-81F9BCACC7D3Q36474267-F1AA36A5-BAE9-43D4-A713-832403DAF657Q36684230-D5C19460-A9BD-4E16-942C-CDF4BB0AE84DQ36733178-B3C5B8E4-5F70-4FEC-B9D2-444CA0733CC3Q36785943-AF8FFB27-AC91-453A-9EFC-739B9F464B4BQ36975260-93BC073D-FDA6-4EFB-805E-4736BC65A7B4Q37012717-3D8CF02A-6B43-4833-AEBB-46B31C19F719Q37345354-EF0E94A1-B081-4F22-A4D6-9002FEAEAF37Q37370796-A5CB7D9A-0697-48F0-87F2-A299CACF6599Q37415946-E1B7DE19-7613-4433-95C0-0176C7EB860AQ37704785-F1134AE8-74D0-4DBE-A936-6C76E514B0FAQ37815569-53212A48-5E08-402B-BB1B-956A8F8ECA06Q38303804-D3521737-9AB4-4245-8A9D-C6C346D1731CQ38313243-FB934C31-7819-4542-8F7A-FE242BB17B4B
P2860
hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
hpttg, a human homologue of ra ...... l activation function of hPTTG
@ast
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en-gb
hpttg, a human homologue of ra ...... l activation function of hPTTG
@nl
type
label
hpttg, a human homologue of ra ...... l activation function of hPTTG
@ast
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en-gb
hpttg, a human homologue of ra ...... l activation function of hPTTG
@nl
prefLabel
hpttg, a human homologue of ra ...... l activation function of hPTTG
@ast
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en-gb
hpttg, a human homologue of ra ...... l activation function of hPTTG
@nl
P2093
P921
P3181
P356
P1433
P1476
hpttg, a human homologue of ra ...... l activation function of hPTTG
@en
P2093
A Domínguez
F Ramos-Morales
J A Pintor-Toro
M Tortolero
P2888
P304
P3181
P356
10.1038/SJ.ONC.1202140
P407
P577
1998-10-29T00:00:00Z
P5875
P6179
1024207746